PUBLICATION

Macrophages warrant Mauthner cell axon regrowth by preventing late-stage hyperglycemia in zebrafish

Authors
Bai, J., Lai, S., Huang, Y., Liu, J., Huang, Z., Xu, J.
ID
ZDB-PUB-260507-1
Date
2026
Source
Open Biology   16: (Journal)
Registered Authors
Huang, Zhujuan, Lai, Siting, Xu, Jin
Keywords
axon regeneration, glucose homeostasis, macrophage, zebrafish
MeSH Terms
none
PubMed
42089279 Full text @ Open Biol.
Abstract
Axonal regeneration in the central nervous system is imperative for functional restoration following spinal cord injury (SCI). Myeloid cells are key regulators of axonal regeneration, yet their roles are not fully revealed. SCI perturbs glucose metabolism; however, its precise impact on axonal regeneration remains undefined. Moreover, whether myeloid cells orchestrate glucose metabolic responses to facilitate regeneration is unclear. Here, using the zebrafish Mauthner cell axon transection model, we demonstrate that following SCI, myeloid cell deficiency leads to a late-stage glucose surge, which leads to impaired axonal regeneration. We further identify glucagon signalling as a critical molecular determinant of this metabolic dysregulation and show that targeted mutations in gcga or its receptors (gcgra, gcgrb) rescue the axonal regeneration defects caused by myeloid cell deficiency. Finally, cell-depletion experiments demonstrated that macrophages are responsible for the late-stage hyperglycemia and defective axon regeneration of Mauthner cells. These findings suggest that glucose metabolism plays a critical role in macrophage-warranted axon regeneration in the spinal cord, positioning glucose homeostasis as a potential therapeutic target for enhancing axon regeneration and recovery.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping